Intervention

Red Light Therapy

Photobiomodulation (Red and Near-Infrared Light Therapy)

Non-thermal light exposure using specific red (600-700nm) and near-infrared (700-1000nm) wavelengths to stimulate mitochondrial function and reduce inflammation.

Editor approved Evidence: Tier 3
Research snapshot FDA-cleared for specific indications (wound healing, pain, hair loss). Widely available as consumer wellness devices. Not approved as systemic anti-aging treatment.
Updated 2026-08-11
Red and near-infrared light therapy has well-established mechanistic evidence for mitochondrial stimulation via cytochrome c oxidase absorption. Clinical evidence is strongest for wound healing, skin rejuvenation, and pain. Systemic anti-aging and longevity claims lack large RCTs with hard endpoints.
Evidence tierTier 3, Mixed human evidence, mechanism plausible
Typical dose5-15 minute sessions, 3-5 times per week. Irradiance typically 10-200 mW/cm2 at the skin. Wavelengths commonly 660nm (red) and 850nm (near-infrared). Distance from panel 6-24 inches.
SafetyGenerally considered safe with low risk of adverse effects when used within recommended parameters. Eye protection required for near-infrared exposure. Overdose can theoretically cause oxidative stress rather than benefit. No reported serious adverse events in clinical trials to date.
Categorylight therapy
Last verified2026-08-11

What it is

Red light therapy, or photobiomodulation (PBM), uses specific wavelengths of red (630-700nm) and near-infrared (700-1000nm) light to stimulate cellular processes. Unlike infrared sauna, PBM is primarily non-thermal, working through cellular photoreceptors rather than heat stress.

How it works

The primary mechanism is absorption of red and near-infrared photons by cytochrome c oxidase (CCO), the final enzyme in the mitochondrial electron transport chain. This absorption is proposed to increase ATP production, reduce reactive oxygen species at therapeutic doses, and trigger downstream signaling pathways involved in repair, inflammation reduction, and cellular resilience. Effects are highly wavelength-, dose-, and tissue-dependent.

Evidence

Clinical evidence is strongest for wound healing, skin rejuvenation, and pain management. Multiple RCTs support these indications. The mechanistic evidence for mitochondrial benefits is well-established in laboratory studies. However, systemic anti-aging claims, including epigenetic age reduction or lifespan extension, lack large RCTs with hard endpoints. Most longevity-related claims are extrapolated from mechanistic data.

What to know

Dosing matters enormously. Too little light produces no effect. Too much can theoretically cause oxidative stress rather than benefit. The biphasic dose-response curve (hormesis) means more is not always better. Key parameters include wavelength (commonly 660nm red and 850nm near-infrared), irradiance at the skin (10-200 mW/cm2), duration (5-15 minutes), and distance from the light source. Consistency (3-5 sessions per week) matters more than single long sessions.

Practical considerations

Home LED panels cost $100-2,000 depending on size and power. Clinical sessions available at dermatology clinics and wellness centers. Eye protection is essential when using near-infrared panels. Results for skin typically appear after 4-8 weeks of consistent use. Systemic benefits beyond skin and local pain are not well-established.

Further reading

Curated external sources for a deeper dive. External links open in a new tab.